Efficacy and Safety of Atorvastatin and Ezetimibe (10/10mg) Fixed Dose Combination Versus Atorvastatin (20mg) Monotherapy in Bangladeshi Population

Clinical trial NCT06789432 · RECRUITING

Trial details

NCT number: NCT06789432
Sponsor: Dr. Md. Alimur Reza
Status: RECRUITING
Phase: Phase 4
Study type: INTERVENTIONAL

Hyperlipidemia (E.G., Hypercholesterolemia)

Start date: 2025-02-01
Primary completion: 2025-10-01
Enrollment: 500

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.